ECSP993022A - ARILTIAZOLIDINDIONA DERIVATIVES - Google Patents
ARILTIAZOLIDINDIONA DERIVATIVESInfo
- Publication number
- ECSP993022A ECSP993022A ECSP993022A ECSP993022A EC SP993022 A ECSP993022 A EC SP993022A EC SP993022 A ECSP993022 A EC SP993022A EC SP993022 A ECSP993022 A EC SP993022A
- Authority
- EC
- Ecuador
- Prior art keywords
- ariltiazolidindiona
- derivatives
- thiazolidinediones
- hypertriglyceridemia
- parr
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Las 5-aril-2,4 -tiazolidindionas son potentes agonistas de PPAR y, por lo tanto, son útiles en el tratamiento, control o prevención de la diabetes, hiperglicemia, hiperlipidemia (incluyendo hipercolesterolemia e hipertrigliceridemia), arterosclerosis, obesidad, restenosis vascular y otras enfermedades, desórdenes y condiciones mediadas por PARR(( (y/o (5-Aryl-2,4-thiazolidinediones are potent PPAR agonists and therefore useful in the treatment, control, or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis and other PARR-mediated diseases, disorders and conditions (((and / or (
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993022 ECSP993022A (en) | 1999-06-17 | 1999-06-17 | ARILTIAZOLIDINDIONA DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993022 ECSP993022A (en) | 1999-06-17 | 1999-06-17 | ARILTIAZOLIDINDIONA DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993022A true ECSP993022A (en) | 1999-08-12 |
Family
ID=42044011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993022 ECSP993022A (en) | 1999-06-17 | 1999-06-17 | ARILTIAZOLIDINDIONA DERIVATIVES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993022A (en) |
-
1999
- 1999-06-17 EC ECSP993022 patent/ECSP993022A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE333448T1 (en) | ARYLTHIAZOLIDINEDIONE AND ARYLOXA ZOLIDINEDIONE DERIVATIVES | |
| ATE352545T1 (en) | ARYLTHIAZOLIDINDONE DERIVATIVES | |
| WO2002026729A3 (en) | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders | |
| AU7705601A (en) | N-substituted indoles useful in the treatment of diabetes | |
| WO2002060434A3 (en) | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders | |
| NO20015607D0 (en) | Glukagonantagonister / inversagonister | |
| WO2002060388A3 (en) | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders | |
| NO20005387D0 (en) | 3- (amino or aminoalkyl) pyridinone derivatives and their use in the treatment of HIV-related diseases | |
| HUP0103114A2 (en) | Apolipoprotein a-1 agonists and their use to treat dyslipidemic disorders | |
| DE60044041D1 (en) | Exendine for glucagon suppression | |
| NO20043309L (en) | Drug delivery systems for the prevention and treatment of vascular diseases including rapamycin and its derivatives | |
| IL131801A0 (en) | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes | |
| DE69613386D1 (en) | CARBOSTYRIL DERIVATIVE FOR TREATING OPHTHALMOLOGICAL DISEASES | |
| ECSP993022A (en) | ARILTIAZOLIDINDIONA DERIVATIVES | |
| BR0115075A (en) | Benzo'b! Thiophenes and benzo'd! Isothiazoles for cholesterol lowering | |
| DK99993D0 (en) | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES OR BACTERIA | |
| AR018898A1 (en) | DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| BR0112609A (en) | Aniline Derivatives | |
| PT1228031E (en) | MODIFIED 15-HYDROXYETHYTETRAENOIC ACID DERIVATIVES IN THE OMEGA CHAIN AND ITS USE IN THE TREATMENT OF OCULAR SECURA | |
| FI911533A7 (en) | Benzoxazine derivatives, process for their preparation and their use for the treatment or prevention of diseases | |
| NO20013534L (en) | Use of a composition comprising a glucosamine salt or a glucosamine derivative for the manufacture of a medicament for the treatment of human thrombosis | |
| ES2178499T3 (en) | BIOACTIVE IMPLANTS AND PROCEDURE FOR PRODUCTION. | |
| NO307177B1 (en) | Quinolone derivative for the treatment of urinary incontinence, its use, method of preparation and pharmaceutical composition | |
| DOP2001000256A (en) | DERIVATIVES OF ACIDOBENZOPIRANCARBOXILICO FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS. | |
| ES1042279Y (en) | PERFECTED PIECE OF JEWELRY OR JEWELERY. |